New Nanodevice Could Use Solar Energy to Produce Hydrogen

Scientists describe the design of a PSI-GNP-PSII conjugate that could be used as a platform for developing a light-driven, water-splitting nanodevice for generating hydrogen, in Biomedical Spectroscopy and Imaging

June 10, 2020 - Amsterdam, NL – Solar energy is considered by some to be the ultimate solution to address the current energy crisis and global warming and the environmental crises brought about by excessive consumption of fossil fuels. However, this clean and inexhaustible energy source is difficult to capture and store. In a novel study, scientists propose using solar energy to produce hydrogen by splitting water, reports Biomedical Spectroscopy and Imaging. More...

June 10, 2020

Growth Factors and Parkinson’s Disease – Where Next?

International experts review the progress of treatment of Parkinson’s disease with growth factors and recommend the design of future trials, reports the Journal of Parkinson's Disease

June 4, 2020 - Amsterdam, NL – Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson’s disease (PD), but trials have been disappointing. A panel of prominent leaders in the field convened to discuss whether there is a future for this approach and what any future PD trial involving GDNF and other GDNF family neurotrophic factors should consider. Their discussions and recommendations are published in the Journal of Parkinson's Disease. More...

June 4, 2020

COVID-19 May Compound the Social and Economic Burdens of Parkinson’s Disease

Evidence from past epidemics and preclinical research suggests that the COVID-19 pandemic may have a long-lasting impact on the pandemic of Parkinson's disease, scientists write in JPD

May 12, 2020 - Amsterdam, NL – Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD. Writing in the Journal of Parkinson's Disease (JPD), scientists discuss several avenues through which the COVID-19 pandemic might contribute to the expected exponential growth of PD in the coming years, compounding the economic and societal impacts of the disease. More...

May 12, 2020

Passive Immunization May Slow Down SARS-CoV-2 and Boost Immunity in Patients, Buying Time Until Vaccines Are Developed

Using antibodies from recovered patients has been life-saving for other acute infections and should be explored in response to COVID-19, researchers say in the International Journal of Risk & Safety in Medicine

May 12, 2020 - Amsterdam, NL – The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority. However, creating a viable vaccine might take a long time; scientists estimate a vaccine may be available in between 12 and 18 months. A potential interim solution reported in the International Journal of Risk & Safety in Medicine may be a passive vaccine, or passive immummization (PI), which can provide instant, short-term fortification against infectious agents. More...

May 12, 2020